India Proposes Mandatory Anti-Tobacco Advertisements on OTT Platforms

Sep.23.2024
India Proposes Mandatory Anti-Tobacco Advertisements on OTT Platforms
Indian Health Ministry proposes mandatory anti-tobacco ads and disclaimers on OTT platforms to strengthen existing rules.

According to a report from Devdiscourse on September 21, the Indian Ministry of Health has recently released a draft amendment to the anti-tobacco rules for Over-The-Top (OTT) platforms, proposing mandatory broadcast of anti-tobacco health advertisements and disclaimers on OTT platforms. The draft amendment requires non-skippable 30-second health advertisements to be played at the beginning and middle of each movie or show, and static health warnings to be displayed during scenes depicting smoking. These proposals aim to strengthen existing anti-tobacco regulations.


The draft regulation, known as "The Cigarettes and Other Tobacco Products (Advertisement and Regulation of Trade, Production, Supply, and Distribution) Amendment Rules 2024," aims to amend the rules introduced last year, which made India the first country to implement such anti-tobacco measures on OTT platforms. The draft regulation is currently open to the public for feedback, with a deadline of October 13th.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.